These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7608266)

  • 1. Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.
    Fujiyama K; Kiriyama T; Ito M; Nakata K; Yamashita S; Yokoyama N; Nagataki S
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2135-8. PubMed ID: 7608266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy.
    Takamura Y; Miyauchi A; Yabuta T; Kihara M; Ito Y; Miya A
    World J Surg; 2013 Dec; 37(12):2860-5. PubMed ID: 24045966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
    Duan Y; De Luca V; Seeman E
    J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of parathyroid status and Ca and vitamin-D supplementation on bone mass and muscle-bone relationships in 208 Belarussian children after thyroidectomy because of thyroid carcinoma.
    Schneider P; Biko J; Reiners C; Demidchik YE; Drozd VM; Capozza RF; Cointry GR; Ferretti JL
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):444-50. PubMed ID: 15372365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in patients with chronic hypoparathyroidism.
    Abugassa S; Nordenström J; Eriksson S; Sjödén G
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1617-21. PubMed ID: 8501170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and physical determinants of bone mass in late postmenopause.
    Albanese CV; Civitelli R; Tibollo FG; Masciangelo R; Mango D
    Exp Clin Endocrinol Diabetes; 1996; 104(3):263-70. PubMed ID: 8817245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA; Goswami R; Singh N; Gupta N; Seith A
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of ionized calcium one year after hemithyroidectomy: importance of reduced thyroid hormones.
    Lindblom P; Valdemarsson S; Lindergård B; Westerdahl J; Bergenfelz A
    Horm Res; 2001; 55(2):81-7. PubMed ID: 11509864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.
    Garnero P; Borel O; Sornay-Rendu E; Arlot ME; Delmas PD
    J Bone Miner Res; 1996 Jun; 11(6):827-34. PubMed ID: 8725180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.
    Khosla S; Atkinson EJ; Melton LJ; Riggs BL
    J Clin Endocrinol Metab; 1997 May; 82(5):1522-7. PubMed ID: 9141544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term thyroxine treatment and bone mineral density.
    Franklyn JA; Betteridge J; Daykin J; Holder R; Oates GD; Parle JV; Lilley J; Heath DA; Sheppard MC
    Lancet; 1992 Jul; 340(8810):9-13. PubMed ID: 1351654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma.
    Iglesias SG; Dominguez MLM; Herrero EF; Martinez-Pueyo JI; Arroba CM; Diaz-Guerra GM; Hawkins Carranza F
    Surgery; 2019 Apr; 165(4):814-819. PubMed ID: 30554726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.